Hikma Pharmaceuticals PLC/ GB00B0LCW083 /
30/08/2024 14:07:28 | Chg. +11.00 | Volume | Bid14:09:15 | Ask30/08/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2,002.00GBX | +0.55% | 9,228 Turnover(GBP): 184,979.6550 |
2,000.00Bid Size: 57 | 2,004.00Ask Size: 120 | 4.43 bill.GBP | - | - |
GlobeNewswire
25/02/2021
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
GlobeNewswire
26/01/2021
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insu...
GlobeNewswire
09/01/2020
Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Usi...
GlobeNewswire
03/06/2019
Gout Therapeutic Market is projected to reach US$ 3820 Million by 2027- TMR